Candriam Equities L Biotechnology Class I EUR Hedged Cap

Register to Unlock Ratings
Performance History28/02/2025
Growth of 1,000 (GBP) Advanced Graph
Candriam Equities L Biotechnology Class I EUR Hedged Cap
Fund-8.7-0.12.5-3.52.2
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
13/03/2025
 EUR 2029.87
Day Change -1.24%
Morningstar Category™ Other Equity
ISIN LU1006082199
Fund Size (Mil)
13/03/2025
 USD 1293.13
Share Class Size (Mil)
13/03/2025
 EUR 14.09
Max Initial Charge -
Ongoing Charge
28/02/2025
  0.81%
Investment Objective: Candriam Equities L Biotechnology Class I EUR Hedged Cap
The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund may be appropriate for investors who wish to achieve this objective over a long investment holding period and who are aware of, understand and are able to bear the specific risks of the sub-fund.
Returns
Trailing Returns (GBP)13/03/2025
YTD0.15
3 Years Annualised5.02
5 Years Annualised4.88
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Linden Thomson
29/02/2024
Servaas Michielssens
30/04/2024
Inception Date
04/12/2015
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Candriam Equities L Biotechnology Class I EUR Hedged Cap31/01/2025
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.490.0098.49
Bond0.000.000.00
Property0.000.000.00
Cash1.510.001.51
Other0.000.000.00
Top 5 Regions%
United States77.72
Eurozone9.69
Europe - ex Euro6.11
United Kingdom2.93
Asia - Emerging2.11
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Gilead Sciences IncHealthcareHealthcare6.27
Amgen IncHealthcareHealthcare5.76
Vertex Pharmaceuticals IncHealthcareHealthcare5.53
Alnylam Pharmaceuticals IncHealthcareHealthcare4.98
Regeneron Pharmaceuticals IncHealthcareHealthcare4.75
Candriam Equities L Biotechnology Class I EUR Hedged Cap

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures